TODAY   |  December 12, 2013

FDA advisory committee oks no-needle allergy drug

A Food and Drug Administration advisory committee has ruled that the drug Oralair is an effective treatment for allergy sufferers that doesn’t require a needle. NBC News’ Chief Medical Editor Dr. Nancy Snyderman reports.

Share This:

This content comes from Closed Captioning that was broadcast along with this program.

>>> this morning, there is big news about an alternative treatment for allergy sufferers that doesn't require needles. wednesday, an advisory committee ruled the drug is effective and safe for people over the age of 10. nbc news medical editor dr. nancy sneiderman has the details.

>> reporter: luisa and her daughter have severe allergies.

>> we have runny nose, puffy eye,ichy throat, coughing and sometimes hives.

>> reporter: every morning they pack emergency kits and they both get regular allergy shots , but monthly or weekly trips to the doctor's office may soon be a thing of the past, 2.5 million americans getting allergy injections. two drugs that treat graph allergies already proved in europe are being reviewed by the fda. they are daily use pills that dissolve under the tongue and can be taken at home. an allergist for merck.

>> the two big groups that i see that would really benefit from this therapy are very busy people that can't fit a visit to a doctor's office for a shot into their busy schedules and those who are needle adverse.

>> reporter: but there is a tradeoff. the pills cover only specific graph pollen, while shots can offer broader protection to more allergens and be personalized for each individual. but some doctors caution while the pills may be more convenient, no one should sacrifice a doctor's supervisors. for "today," dr. nancy sneiderman, nbc news, new york.